As previously reported, Wells Fargo analyst Matthew Akers downgraded TransDigm to Equal Weight from Overweight with a price target of $660, down from $735. The analyst sees less upside for the stock with worsening mix trends and more expensive capital. TransDigm trades at a 20%-30% premium to its historical multiple, which Akers expects to shrink as industry conditions normalize.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on TDG: